BMC now audits the tools Compuware sold you.

BMC acquired Compuware (BMC) in 2020. The developer and fault diagnosis tools your teams rely on, Topaz Workbench, Xpediter, Abend-AID, File-AID, and Strobe, now sit in the BMC AMI DevX line and under BMC's commercial and compliance practices. The software did not change. The owner, the contract motion, and the audit posture did.

The pattern we commonly observe: an audit of the former Compuware tools that proceeds as if current BMC paper governs, when in fact a meaningful part of the estate still runs under pre acquisition Compuware agreements with different audit rights, capacity definitions, and metrics. Letting the auditor pick which terms apply is the first and most expensive mistake.

These tools are typically licensed by mainframe capacity for the environments where they run, so the audit turns on how capacity is counted. The recurring exposures are capacity that grew through a hardware refresh or an LPAR reconfiguration without the entitlement being revisited, tools that spread to more environments than were licensed, and scope that quietly expands to include development, test, or disaster recovery that the agreement treats differently. Each is a place where the vendor's count and the contract's terms diverge, and each is challengeable with validated deployment data mapped against entitlement, product by product and LPAR by LPAR.

We start where the vendor would rather not: establishing which contract governs each product, then holding the audit to that clause. We validate capacity by LPAR, correct the non production treatment, reconcile the refresh history, and rebuild entitlement in full before any shortfall is accepted. Directionally, across 500+ engagements and $180M+ in negotiated mainframe spend, audit defenses of this kind typically bring findings and the settlements that follow 20 to 35 percent below the opening claim. On an active audit notice, we mobilize within 48 hours.